Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

National Cancer Institute (NCI) · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
extrahepatic bile duct adenocarcinoma, gallbladder adenocarcinoma, gallbladder adenocarcinoma with squamous metaplasia, hilar cholangiocarcinoma, recurrent extrahepatic bile duct carcinoma, recurrent gallbladder carcinoma, undifferentiated gallbladder carcinoma, unresectable extrahepatic bile duct carcinoma, unresectable gallbladder carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 801189
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.